 Antipsychotic Agents
"Antipsychotic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.
| Descriptor ID |
D014150
|
| MeSH Number(s) |
D27.505.696.277.950.040 D27.505.954.427.210.950.040 D27.505.954.427.700.872.331
|
| Concept/Terms |
Antipsychotic Agents- Antipsychotic Agents
- Agents, Antipsychotic
- Antipsychotics
- Major Tranquilizers
- Tranquilizers, Major
- Tranquillizing Agents, Major
- Agents, Major Tranquillizing
- Major Tranquillizing Agents
- Neuroleptic Drugs
- Drugs, Neuroleptic
- Neuroleptics
- Tranquilizing Agents, Major
- Agents, Major Tranquilizing
- Major Tranquilizing Agents
- Antipsychotic Drugs
- Drugs, Antipsychotic
- Neuroleptic Agents
- Agents, Neuroleptic
Antipsychotic Effect- Antipsychotic Effect
- Effect, Antipsychotic
- Antipsychotic Effects
- Effects, Antipsychotic
|
Below are MeSH descriptors whose meaning is more general than "Antipsychotic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antipsychotic Agents".
This graph shows the total number of publications written about "Antipsychotic Agents" by people in this website by year, and whether "Antipsychotic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1998 | 1 | 1 | 2 | | 1999 | 3 | 0 | 3 | | 2000 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 | | 2003 | 4 | 1 | 5 | | 2004 | 10 | 2 | 12 | | 2005 | 4 | 0 | 4 | | 2006 | 5 | 4 | 9 | | 2007 | 8 | 2 | 10 | | 2008 | 10 | 3 | 13 | | 2009 | 5 | 0 | 5 | | 2010 | 4 | 0 | 4 | | 2011 | 8 | 2 | 10 | | 2012 | 5 | 3 | 8 | | 2013 | 5 | 1 | 6 | | 2014 | 13 | 6 | 19 | | 2015 | 4 | 1 | 5 | | 2016 | 7 | 2 | 9 | | 2017 | 8 | 3 | 11 | | 2018 | 4 | 2 | 6 | | 2019 | 1 | 2 | 3 | | 2020 | 1 | 0 | 1 | | 2021 | 4 | 0 | 4 | | 2022 | 2 | 0 | 2 | | 2023 | 1 | 0 | 1 | | 2024 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Antipsychotic Agents" by people in Profiles.
-
Borgelt LM, Bliss K, Matson J, Cajuste B, Kuang X, Toohey M, Pace W, Shemesh E, Lo S, Olczyk A, Gleason K, Pincus H, Kleinman LC. Prevalence of contraindicated combinations amid behavioral and mental health medications filled in a pediatric population. BMC Prim Care. 2024 Jul 30; 25(1):276.
-
Cole JB, Stang JL, Collins JD, Klein LR, DeVries PA, Smith J, Pepin LC, Fuchs RT, Driver BE. Comparing Intubation Rates in Patients Receiving Parenteral Olanzapine With and Without a Parenteral Benzodiazepine in the Emergency Department. Ann Emerg Med. 2024 Dec; 84(6):658-667.
-
Mart MF, Boehm LM, Kiehl AL, Gong MN, Malhotra A, Owens RL, Khan BA, Pisani MA, Schmidt GA, Hite RD, Exline MC, Carson SS, Hough CL, Rock P, Douglas IS, Feinstein DJ, Hyzy RC, Schweickert WD, Bowton DL, Masica A, Orun OM, Raman R, Pun BT, Strength C, Rolfsen ML, Pandharipande PP, Brummel NE, Hughes CG, Patel MB, Stollings JL, Ely EW, Jackson JC, Girard TD. Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial. Lancet Respir Med. 2024 Aug; 12(8):599-607.
-
Dodd K, Legget KT, Cornier MA, Novick AM, McHugo M, Berman BD, Lawful BP, Tregellas JR. Relationship between functional connectivity and weight-gain risk of antipsychotics in schizophrenia. Schizophr Res. 2024 05; 267:173-181.
-
Thurstone C, Loh R, Foreman K, Thurstone CA, Wolf C. Program Evaluation to Aid Choice of Aripiprazole or Risperidone for Hospitalized Adolescents with Cannabis Use Disorder and Psychosis. J Child Adolesc Psychopharmacol. 2023 10; 33(8):332-336.
-
Schamiloglu S, Lewis E, Keeshen CM, Hergarden AC, Bender KJ, Whistler JL. Arrestin-3 Agonism at Dopamine D3 Receptors Defines a Subclass of Second-Generation Antipsychotics That Promotes Drug Tolerance. Biol Psychiatry. 2023 10 01; 94(7):531-542.
-
Damme KSF, Gupta T, Ristanovic I, Kimhy D, Bryan AD, Mittal VA. Exercise Intervention in Individuals at Clinical High Risk for Psychosis: Benefits to Fitness, Symptoms, Hippocampal Volumes, and Functional Connectivity. Schizophr Bull. 2022 11 18; 48(6):1394-1405.
-
Bleacher H, Koerperich L, Malam N, DeSanto K. Are antipsychotics effective adjunctive Tx for patients with moderate-to-severe depression? J Fam Pract. 2022 07; 71(6):E13-E15.
-
Lohr WD, Jawad K, Feygin Y, Le J, Creel L, Pasquenza N, Williams PG, Jones VF, Myers J, Davis DW. Antipsychotic Medications for Low-Income Preschoolers: Long Duration and Psychotropic Medication Polypharmacy. Psychiatr Serv. 2022 05; 73(5):510-517.
-
Cotes RO, Janjua AU, Broussard B, Lazris D, Khan A, Jiao Y, Kopelovich SL, Goldsmith DR. A Comparison of Attitudes, Comfort, and Knowledge of Clozapine Among Two Diverse Samples of US Psychiatrists. Community Ment Health J. 2022 04; 58(3):517-525.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|